Learning Center

26 July 2021

The Complex Demands of Personalized Medicine Supply Chains.

Outsourcing-Pharma and Nina Vas, Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, discuss the specific requirements involved in the clinical trial supply chain for cell and gene therapies and other personalized medicines.

These differ dramatically from small molecule therapies and require an appropriately personalized approach.

You can rely on us to mitigate risk and reduce the complexity of personalized medicine supply chains because we are a wholly owned subsidiary of UPS and the essential clinical part of UPS Healthcare. With Marken, BOMI Group, and Polar Speed included, the UPS Healthcare network staffs 199 locations with 10,000+ employees worldwide.

Marken Logo

Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.